Taiwan Advance Bio-Pharmaceutical Inc. (TPEX:4186)
Taiwan · Delayed Price · Currency is TWD 10.30
-0.20 (-1.90%)
Aug 1, 2025, 2:59 PM CST
TPEX:4186 Revenue
In the year 2024, Taiwan Advance Bio-Pharmaceutical had annual revenue of 354.17M TWD with 12.09% growth. Taiwan Advance Bio-Pharmaceutical had revenue of 202.51M in the half year ending December 31, 2024, with 34.73% growth.
Revenue
354.17M
Revenue Growth
+12.09%
P/S Ratio
2.62
Revenue / Employee
2.15M
Employees
165
Market Cap
927.00M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 354.17M | 38.19M | 12.09% |
| Dec 31, 2023 | 315.98M | -2.25M | -0.71% |
| Dec 31, 2022 | 318.24M | 74.87M | 30.77% |
| Dec 31, 2021 | 243.36M | 7.79M | 3.31% |
| Dec 31, 2020 | 235.57M | 29.77M | 14.47% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Caliway Biopharmaceuticals | 40.47M |
| PharmaEssentia | 11.34B |
| Bora Pharmaceuticals Co., LTD. | 20.87B |
| Lotus Pharmaceutical | 19.12B |
| Oneness Biotech | 117.33M |
| Polaris Group | 87.67M |
| Center Laboratories | 1.63B |
| Pegavision | 6.67B |